194 related articles for article (PubMed ID: 31659408)
1. miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes.
Ventriglia G; Mancarella F; Sebastiani G; Cook DP; Mallone R; Mathieu C; Gysemans C; Dotta F
Diabetologia; 2020 Jan; 63(1):124-136. PubMed ID: 31659408
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
Fornari TA; Donate PB; Assis AF; Macedo C; Sakamoto-Hojo ET; Donadi EA; Passos GA
PLoS One; 2015; 10(11):e0142688. PubMed ID: 26606254
[TBL] [Abstract][Full Text] [Related]
3. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.
Lakhter AJ; Pratt RE; Moore RE; Doucette KK; Maier BF; DiMeglio LA; Sims EK
Diabetologia; 2018 May; 61(5):1124-1134. PubMed ID: 29445851
[TBL] [Abstract][Full Text] [Related]
4. A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis-Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes.
Sassi G; Licata G; Ventriglia G; Wouters A; Lemaitre P; Seurinck R; Mori A; Grieco GE; Bissenova S; Ellis D; Caluwaerts S; Rottiers P; Vandamme N; Mathieu C; Dotta F; Gysemans C; Sebastiani G
Diabetes; 2023 Oct; 72(10):1470-1482. PubMed ID: 37494666
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
Samandari N; Mirza AH; Nielsen LB; Kaur S; Hougaard P; Fredheim S; Mortensen HB; Pociot F
Diabetologia; 2017 Feb; 60(2):354-363. PubMed ID: 27866223
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
Front Immunol; 2019; 10():1637. PubMed ID: 31396209
[TBL] [Abstract][Full Text] [Related]
7. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses.
Assmann TS; Recamonde-Mendoza M; Costa AR; Puñales M; Tschiedel B; Canani LH; Bauer AC; Crispim D
Acta Diabetol; 2019 Jan; 56(1):55-65. PubMed ID: 30167868
[TBL] [Abstract][Full Text] [Related]
9. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes.
Garavelli S; Bruzzaniti S; Tagliabue E; Di Silvestre D; Prattichizzo F; Mozzillo E; Fattorusso V; La Sala L; Ceriello A; Puca AA; Mauri P; Strollo R; Marigliano M; Maffeis C; Petrelli A; Bosi E; Franzese A; Galgani M; Matarese G; de Candia P
Diabetologia; 2020 Dec; 63(12):2699-2712. PubMed ID: 32728892
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema.
Grieco GE; Sebastiani G; Eandi CM; Neri G; Nigi L; Brusco N; D'Aurizio R; Posarelli M; Bacci T; Benedetto E; Fruschelli M; Orlandini M; Galvagni F; Dotta F; Tosi GM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023063
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p.
Sebastiani G; Guarino E; Grieco GE; Formichi C; Delli Poggi C; Ceccarelli E; Dotta F
Front Endocrinol (Lausanne); 2017; 8():345. PubMed ID: 29312141
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.
Mazzeo A; Beltramo E; Lopatina T; Gai C; Trento M; Porta M
Exp Eye Res; 2018 Nov; 176():69-77. PubMed ID: 30008390
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies.
Zhu H; Leung SW
Diabetologia; 2015 May; 58(5):900-11. PubMed ID: 25677225
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction.
Coskunpinar E; Cakmak HA; Kalkan AK; Tiryakioglu NO; Erturk M; Ongen Z
Gene; 2016 Oct; 591(1):90-96. PubMed ID: 27374153
[TBL] [Abstract][Full Text] [Related]
16. miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.
Zurawek M; Dzikiewicz-Krawczyk A; Izykowska K; Ziolkowska-Suchanek I; Skowronska B; Czainska M; Podralska M; Fichna P; Przybylski G; Fichna M; Nowak J
Diabetes Res Clin Pract; 2018 Aug; 142():146-153. PubMed ID: 29859273
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
[TBL] [Abstract][Full Text] [Related]
18. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus.
Massaro JD; Polli CD; Costa E Silva M; Alves CC; Passos GA; Sakamoto-Hojo ET; Rodrigues de Holanda Miranda W; Bispo Cezar NJ; Rassi DM; Crispim F; Dib SA; Foss-Freitas MC; Pinheiro DG; Donadi EA
Mol Cell Endocrinol; 2019 Jun; 490():1-14. PubMed ID: 30926524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
